AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.


Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Telephone: +64 9 488 0232
Facsimile: n/a
Website: www.aftpharm.com
First Listed: 22/12/2015
Balance Date: 31 March
AGM: 01/08/2025

Directors and Executives

Hartley Atkinson
Executive Director
Marree Atkinson
Executive Director
David Flacks
Chairman
Andrew Lane
Director
Malcolm Tubby
CFO / Company Secretary
Ted Witek
Independent Non-Executive Director
Allison Yorston
Independent Director

Announcements

Title Date Type
September Quarter FY2026 Investor Update Thu, Sep 25 2025 08:30 am GENERAL
Disclosure of Directors and Senior Managers Relevant Int Mon, Sep 01 2025 05:09 pm SHINTR
Results of 2025 Annual Shareholder Meeting Mon, Aug 04 2025 08:30 am GENERAL
2025 ASM Release, Chairs address & presentation Fri, Aug 01 2025 08:47 am GENERAL
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jul 04 2025 08:30 am SHINTR
June Quarter FY 2026 Investor Update Tue, Jul 01 2025 08:35 am GENERAL
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jun 27 2025 08:42 am SHINTR
Notice of Annual Meeting of Shareholders 2025 Fri, Jun 27 2025 08:39 am MEETING
Annual Meeting and Closing Date for Director Nominations Fri, May 30 2025 08:59 am MEETING
AFT and Hikma extend US Maxigesic Cooperation Mon, May 26 2025 08:38 am GENERAL

Major Holdings Announcements

Date Name No. Held % Current
07/11/24 Accident Compensation Corporation 7,523,033 6.05 7.17
16/09/20 Forsyth Barr Group Limited and Fors 1,617,818 71.25 1.55
15/06/20 Hartley Campbell Atkinson and Colin 72,031,609 72.60 69.82
15/06/20 The CRG Persons - 15.99 -
25/05/17 AFT Pharmaceuticals Limited - 72.34 -

Director’s Interests Announcements

Date Name No. Held % Details Other
01/09/25 David Flacks 196,486 - - -
04/07/25 Hartley Campbell Atkins 73,127,322 - - -
27/11/24 Andrew Lane 95,000 - - -
18/09/23 Jon Lamb 271,314 - - -
14/04/21 Malcolm Tubby 143,892 - - -
10/08/20 Hartley Atkinson 72,899,435 - - -
22/08/18 James Burns 125,417 - - -
19/06/17 John Douglas Wilson 56,689 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/09/2025


Markets News

ASB, IAG legal payouts prompt differing verdicts
Markets

ASB, IAG legal payouts prompt differing verdicts

ASB flagged the class action as a contingent liability.

Finance

ANZ vows to fight CCCFA class action despite ASB settlement

“ANZ NZ will continue to defend its case. Our position hasn’t changed.” 

ANZ vows to fight CCCFA class action despite ASB settlement
Markets Market Close

NZ sharemarket up 0.3% despite business confidence drop

The S&P/NZX 50 Index closed at 13,531.29, up 42.05 points or 0.31%.

Graham Skellern 07 Oct 2025
NZ sharemarket up 0.3% despite business confidence drop
Finance

ASB settles CCCFA class action for hefty $135.6m

 It ended a four-year class action centred on disclosure obligations.

Andy Macdonald 07 Oct 2025
ASB settles CCCFA class action for hefty $135.6m